Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Stock
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
2,662,960
-
Shares change
-
+69,056
-
Total reported value, excl. options
-
$3,369,000
-
Value change
-
+$56,120
-
Number of buys
-
3
-
Number of sells
-
-6
-
Price
-
$1.27
Significant Holders of SUMMIT THERAPEUTICS INC COM - Stock (SMMT) as of Q2 2019
11 filings reported holding SMMT - SUMMIT THERAPEUTICS INC COM - Stock as of Q2 2019.
SUMMIT THERAPEUTICS INC COM - Stock (SMMT) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,662,960 shares
.
Largest 10 shareholders include LANSDOWNE PARTNERS (UK) LLP (1,596,666 shares), Polar Capital LLP (344,681 shares), MORGAN STANLEY (244,201 shares), Bank of New York Mellon Corp (216,897 shares), ACADIAN ASSET MANAGEMENT LLC (173,385 shares), RENAISSANCE TECHNOLOGIES LLC (84,530 shares), DEUTSCHE BANK AG\ (1,900 shares), GROUP ONE TRADING, L.P. (700 shares), Virtu Financial LLC (0 shares), and CITADEL ADVISORS LLC (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.